Literature DB >> 16552081

Human neutrophil calprotectin reduces the susceptibility of Borrelia burgdorferi to penicillin.

Ruth R Montgomery1, Kimberly Schreck, Xiaomei Wang, Stephen E Malawista.   

Abstract

Borrelia burgdorferi, the spirochetal agent of Lyme disease, is susceptible to killing by a variety of polymorphonuclear leukocyte (PMN) components. Some are most effective against metabolically active B. burgdorferi. The abundant PMN cytoplasmic protein calprotectin, elevated 10- to 100-fold in inflammation, inhibits the growth of spirochetes through chelation of the essential cation, Zn. Since the action of some therapeutic antibiotics depends on bacterial division, we investigated the antibiotic sensitivities of spirochetes in calprotectin. In physiologic calprotectin, B. burgdorferi is not eliminated by therapeutic doses of penicillin G; in contrast, doxycycline is effective. Calprotectin may modify the clearance of spirochetes at sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552081      PMCID: PMC1418918          DOI: 10.1128/IAI.74.4.2468-2472.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation.

Authors:  K Roulin; G Hagens; R Hotz; J H Saurat; J H Veerkamp; G Siegenthaler
Journal:  Exp Cell Res       Date:  1999-03-15       Impact factor: 3.905

2.  Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation.

Authors:  Sylvie Berthier; Marie-Helene Paclet; Sandra Lerouge; Florence Roux; Sabrina Vergnaud; Anthony W Coleman; Francoise Morel
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

3.  Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide.

Authors:  Karen Vandal; Pascal Rouleau; Annie Boivin; Carle Ryckman; Mariève Talbot; Philippe A Tessier
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils.

Authors:  R A Newton; N Hogg
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

5.  Elastase is the only human neutrophil granule protein that alone is responsible for in vitro killing of Borrelia burgdorferi.

Authors:  R Garcia; L Gusmani; R Murgia; C Guarnaccia; M Cinco; G Rottini
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin.

Authors:  T Okutomi; T Tanaka; S Yui; M Mikami; M Yamazaki; S Abe; H Yamaguchi
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

Review 7.  Adaptation of Borrelia burgdorferi in the vector and vertebrate host.

Authors:  Utpal Pal; Erol Fikrig
Journal:  Microbes Infect       Date:  2003-06       Impact factor: 2.700

8.  Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi.

Authors:  Denise Lusitani; Stephen E Malawista; Ruth R Montgomery
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals.

Authors:  Chad S Brooks; P Scott Hefty; Sarah E Jolliff; Darrin R Akins
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.

Authors:  Carle Ryckman; Shaun R McColl; Karen Vandal; Rinaldo de Médicis; André Lussier; Patrice E Poubelle; Philippe A Tessier
Journal:  Arthritis Rheum       Date:  2003-08
View more
  8 in total

Review 1.  Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle.

Authors:  Felipe C Cabello; Henry P Godfrey; Julia V Bugrysheva; Stuart A Newman
Journal:  Environ Microbiol       Date:  2017-09-11       Impact factor: 5.491

2.  Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis.

Authors:  Ruth R Montgomery; Carmen J Booth; Xiaomei Wang; Victoria A Blaho; Stephen E Malawista; Charles R Brown
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

3.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Authors:  Øystein Brorson; Sverre-Henning Brorson; John Scythes; James MacAllister; Andrew Wier; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

4.  Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.

Authors:  Kenneth A Cornell; Shekerah Primus; Jorge A Martinez; Nikhat Parveen
Journal:  J Antimicrob Chemother       Date:  2009-04-17       Impact factor: 5.790

5.  Antimicrobial action of calprotectin that does not involve metal withholding.

Authors:  Angelique N Besold; Edward M Culbertson; Lily Nam; Ryan P Hobbs; Alisa Boyko; C Noel Maxwell; Walter J Chazin; Adriana R Marques; Valeria C Culotta
Journal:  Metallomics       Date:  2018-12-12       Impact factor: 4.526

Review 6.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

7.  Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques.

Authors:  Nicholas A Crossland; Xavier Alvarez; Monica E Embers
Journal:  Am J Pathol       Date:  2017-12-12       Impact factor: 4.307

Review 8.  Novel targets and strategies to combat borreliosis.

Authors:  Martin Strnad; Libor Grubhoffer; Ryan O M Rego
Journal:  Appl Microbiol Biotechnol       Date:  2020-01-17       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.